The above findings thus suggested that EGFR targeting could provide a platform for a potential therapeutic approach against TNBC, as targeting EGFR modulated the EMT phenomenon, reduced the metastasis, and inhibited tumor growth. This evidence concerns the gene EGFR and neoplasm.